Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 19, 2013
Effect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated ratsAndreas W Fries, Sherry Dadsetan, Susanne Keiding, et al.
Cell|January 11, 1991
PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic modelM Sasahara, J W Fries, E W Raines, et al.
Carcinogenesis|March 1, 1987
Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol estersS M Fischer, J F O'Connell, C J Conti, et al.
European Journal of Gastroenterology & Hepatology|June 1, 2000
Gastric permeability to sucrose is increased in portal hypertensive gastropathyM R Giofré, G Meduri, S Pallio, et al.
Nature|January 18, 1996
Chondrodysplasia and neurological abnormalities in ATF-2-deficient miceA M Reimold, M J Grusby, B Kosaras, et al.
European Journal of Epidemiology|December 13, 2006
Incidence of Crohn's disease and CARD15 mutation in a small township in SicilyM Cottone, M C Renda, A Mattaliano, et al.
Inflammatory Bowel Diseases|November 27, 2001
Hepatitis B and C virus infection in Crohn's diseaseL Biancone, M Pavia, G Del Vecchio Blanco, et al.
Journal of Crohn'S & Colitis|July 23, 2013
European consensus on the histopathology of inflammatory bowel diseaseF Magro, C Langner, A Driessen, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|February 26, 2014
[Relevance of personal contextual factors of the ICF for use in practical social medicine and rehabilitation]S Grotkamp, W Cibis, A Bahemann, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 7, 2025
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC)D Noviello, W Fries, A Orlando, et al.
Pageof 13